Patisiran Sodium, sold under the brand name Onpattro, is a medication used for the treatment of polyneuropathy in people with hereditary transthyretin-mediated amyloidosis. Reference standards of Patisiran Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Patisiran Sodium - API Standards [catalogue_number] => PA 16 3740000 [category_ids] => ,76,78,70,82, [chemical_name] => [weight] => NA [form] => NA [cas] => 1386913-72-9 [pslug] => 1386913-72-9-patisiran-sodium-api-pa163740000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 16 3740000
CAS :
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
